Liver and gallbladder F8: Liver and gallbladder problems with acid-reflux, general weakness, excessive sweating, pale complexion, low immune system, weak voice and easy bruising or bleeding.
1. Liver diseases: The.F8 formula can increase RNA in liver cells, and GDH, SDH, MAO, G-6-P, G-6-PDH, LDH, ACP, N-Ease readings in liver disease patients are also improved after treatment. Five clinical reports on 171 chronic liver disease patients taking the F8 formula from one to three months, showed 112 were cured (65.49%), 36 significantly improved (21.05%) and 23 improved (13.45%). Another two reports on 158 hepatitis B patients taking F8 for three months found 90 cured (56.96%), 31 significantly improved (27.68%), 23 improved (14.56%) and 14 patients did not respond to the treatment (8.86%).
2. Digestive tract protection: The F8 formula has multiple adjusting effects on the digestive tract. It helps the production of gastric proteins and also helps to restore damaged stomach tissue. In a lab animal test, a treatment group used F8 at 10g/kg, 20g/kg and 30g/Kg in a treatment group, and the comparison group used distilled water. Both groups were fed alcohol, NaOH, HCl and analgesic drugs to observe stomach damage and ulcers. In the treatment group, the incidence of ulcers and stomach damage was much lower than among the comparison group, p<0.01 and p<0.001. F8 also increases PGE2 and cAMP in treated animals to protect stomach tissue.
F8 formula also increases the absorption rate of the intestinea. In a lab test, the glucose residual rate was much lower among the F8 treatment group than in the comparison group, while blood sugar levels are up significantly, p<0.01. In a clinical report of 100 gastritis patients using the F8 formula, 52 were cured, 40 improved and 8 did not respond to the treatment.
3. Constipation and diarrhea: Three reports on 78 chronic constipation patients taking F8 found all cured after three weeks. Five other clinical reports also showed similar effects on constipation patients. Two reports on 49 patients with IBS (irritable bowel syndrome) taking F8 formula for two weeks showed 25 were cured (51.02%), 18 improved (36.73%) and 6 (12.24%) did not improve. There are also reports on using the F8 formula to treat diarrhea in AIDS patients while improving patients' immune systems.
4. Immune system: The F8 formula can increase OKT3 and OKT4 levels in immune- depressed patients. In TB patients, T4 and PHA levels are usually up, while T8 is down. The F8 formula can work as a B-cell stimulant to increase the activity of NK cells. Many lab reports prove the F8 formula has great effects in adjusting the human immune system. According to a report on auto-immune disorder patients taking F8 for 28 days, IgG levels dropped from 2263 mg/dl to 2086 mg/dl, p<0.01. Of 75 low-WBC count patients taking F8 (all patients' WBC counts were lower than 4x 1,000,000/ml before treatment), 38 were cured (50.67%), 25 significantly improved (33.33%), 7 improved (9.33%) and only 5 did not (6.67%). Of 50 patients with CFS (chronic fatigue syndrome) taking F8 for a month, 2 significantly improved (4%), 24 improved (48%) and 24 slightly improved (48%). Various reports indicate F8's effects in prolonging cancer patients' lives from 30.8% to 40.7%. A report from Japan on 24 late-stage liver cancer patients. With14 in the treatment group taking F8 and 10 in the comparison group using western medicine, found all 10 patients in the comparison group had died within 24 weeks while in the treatment group, 6 survived (42.86%) over 24 weeks. A report of 25 liver cancer patients from China also showed similar results.
5. Prolapsed organs: 1) Prolapsed stomach: 5 reports on 198 stomach-prolapse patients using the F8 formula found 118 cured (59.59%), 43 significantly improved (21.72%), 28 improved (14.36%) and only 9 did not improve (4.55%). 2) Prolapsed uterus: Three reports on 29 uterus-prolapse patients taking the F8 formula for a month found all cured after treatment. 3) Prolapsed rectum: Two reports on 202 rectum- prolapse patients, with prolapse histories from three months to three years, all taking F8 or its modifications from one to three months, found 177 were cured (87.62%), 12 significantly improved (5.94%), 10 improved (4.95%) and only 3 patients did not respond to the treatment (1.49%).
6. Low blood pressure: Four reports on 104 LBP patients taking F8 from two to four weeks found 57 cured (54.80%), 26 significantly improved (25%), 17 improved (16.35%) and 4 did not improve (3.85%). Several lab tests also showed similar results.
7. Dizziness: Four reports on 313 patients suffering from dizziness due to various diseases, all taking the F8 formula from three to four weeks found 195 were cured (62.30%), 65 greatly improved (20.76%), 48 improved (15.84%) and only 5 patient did not improve (1.60%).
8. Flu: Two reports on 80 patients taking F8 for an average of four days found all were cured or significantly improved. A report from Japan on 20 flu patients also showed a 70 percent cure rate.
9. Spontaneous pnemothorax: Of 34 spontaneous pnemothorax patients taking F8 or its modifications from 9 to 25 days, 33 were cured and only one did not improve.
10. Milky urine: Six reports of 249 patients taking F8 or its modifications for up to three weeks showed 209 were cured (83.93%), 29 improved (11.64%) and 11 did not improve (4.42%).
11. Kidney and urinary tract stones: 72 patients took F8 for 5 days. All reported their pain was gone; X-ray reports showed the stones in 18 patients had begun to pass, and 6 did not show any stones left on the X-ray.
12. Metrorrgagia and metrostaxis: Three reports on 181 patients taking F8 or its modifications for up to a month found more than 90 percent were cured or significantly improved.
13. Male infertility: Two reports on 100 male patients from Japan show great results. Both sperm count and activity were up 70%. 21 patients' wives got pregnant after treatment. Three more reports also confirmed the effectiveness of F8 to treat male infertility.
14. Pediatric chronic upper respiratory infections: A study examined 200 patients, ranging in age from 1 to 7 years old, more than 75% of whom had 7 or more URIs in the preceding year. Patients were divided evenly into a treatment group and a comparison group. The treatment group had a much lower rate of repeated infections, and their symptoms were much less severe than among the comparison group, p<0.05.
15. Sinus problems: Five reports on 117 patients taking the F8 formula from one to seven months found 77 were cured (65.81%), 30 improved (25.64%) and only 10 did not improve (8.55%). All 77 that were cured did not have any sinus problems for one year.
Toxicity and side effects: In a lab test with 2 x 166g/Kg/d for three days, there were no death among test animals in the following 7 days. A very safe formula with no known side effects.
